56 related articles for article (PubMed ID: 1834972)
1. [Prognostic value of expression of IgG Fc receptors in patients with chronic B-cell lymphoid leukemia].
Schranz V
Orv Hetil; 1991 Oct; 132(43):2359-60, 2363-6. PubMed ID: 1834972
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of the heterogenous expression of IgG Fc receptors in B-cell chronic lymphocytic leukemia.
Schranz V; Gráf F
Ann Hematol; 1992 Mar; 64(3):140-5. PubMed ID: 1571409
[TBL] [Abstract][Full Text] [Related]
3. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
4. [Connection between the expression of IgG Fc receptors and other immunologic and clinical parameters in chronic B-cell lymphoid leukemia. A multiple regression model of Fc receptor expression].
Schranz V
Orv Hetil; 1991 Nov; 132(47):2599-608. PubMed ID: 1956683
[TBL] [Abstract][Full Text] [Related]
5. Clinical tumor cell distribution pattern is a prognostically relevant parameter in patients with B-cell chronic lymphocytic leukemia.
Jaksic O; Vrhovac R; Kusec R; Kardum MM; Pandzic-Jaksic V; Kardum-Skelin I; Planinc-Peraica A; Morabito F; Brugiatelli M; Jaksic B
Haematologica; 2001 Aug; 86(8):827-36. PubMed ID: 11522539
[TBL] [Abstract][Full Text] [Related]
6. T-lymphocytes bearing Fc-receptors for IgG in B-cell chronic lymphocytic leukaemia.
Matolcsy A; Magyarlaki T; Baliko Z; Tornoczky J
Haematologia (Budap); 1985; 18(3):185-91. PubMed ID: 2941348
[TBL] [Abstract][Full Text] [Related]
7. Clinical relevance of the expression of the CD31 ligand for CD38 in patients with B-cell chronic lymphocytic leukemia.
Ibrahim S; Jilani I; O'Brien S; Rogers A; Manshouri T; Giles F; Faderl S; Thomas D; Kantarjian H; Keating M; Albitar M
Cancer; 2003 Apr; 97(8):1914-9. PubMed ID: 12673718
[TBL] [Abstract][Full Text] [Related]
8. Fc receptors, immunoglobulin-binding factors and B chronic lymphocytic leukemia.
Fridman WH; Mathiot C; Montcuit J; Teillaud JL
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):311-5. PubMed ID: 3065731
[TBL] [Abstract][Full Text] [Related]
9. Expression, distribution and specificity of Fc receptors for IgM on murine B cells.
Mathur A; Lynch RG; Köhler G
J Immunol; 1988 Sep; 141(6):1855-62. PubMed ID: 2971716
[TBL] [Abstract][Full Text] [Related]
10. The Fc epsilon R2/CD23 antigen: a hallmark of chronic lymphocytic leukemia B cells.
Almerigogna F; Biagiotti R; Giudizi MG; Alessi A; Ricci M; Bosi A; Romagnani S
Ric Clin Lab; 1989; 19(2):129-38. PubMed ID: 2528201
[TBL] [Abstract][Full Text] [Related]
11. The use of CD38 expression by monoclonal B lymphocytes as a prognostic factor in B-cell chronic lymphocytic leukemia.
Boonstra JG; von't Veer MB; Gratama JW
J Biol Regul Homeost Agents; 2004; 18(3-4):340-6. PubMed ID: 15786702
[TBL] [Abstract][Full Text] [Related]
12. CD31 density is a novel risk factor for patients with B-cell chronic lymphocytic leukaemia.
Mainou-Fowler T; Porteous A; Nicolle A; Proctor SJ; Anderson JJ; Summerfield G
Int J Oncol; 2008 Jul; 33(1):169-74. PubMed ID: 18575763
[TBL] [Abstract][Full Text] [Related]
13. B lymphocyte regulation of the immune system. II. Inhibition of Fc receptor expression of lymphocytes by BEF, a lymphokine of B cell origin.
del Guercio P; Zanetti M; del Guercio MF; Katz DH
J Immunol; 1985 Jun; 134(6):3926-33. PubMed ID: 3157754
[TBL] [Abstract][Full Text] [Related]
14. High intracellular content of cyclin-dependent kinase inhibitor p27(Kip1) in early- and intermediate stage B-cell chronic lymphocytic leukemia lymphocytes predicts rapid progression of the disease.
Wolowiec D; Wojtowicz M; Ciszak L; Kosmaczewska A; Frydecka I; Potoczek S; Urbaniak-Kujda D; Kapelko-Slowik K; Kuliczkowski K
Eur J Haematol; 2009 Apr; 82(4):260-6. PubMed ID: 19187271
[TBL] [Abstract][Full Text] [Related]
15. Expression of thrombospondin receptor (CD36) in B-cell chronic lymphocytic leukemia as an indicator of tumor cell dissemination.
Rutella S; Rumi C; Puggioni P; Barberi T; Di Mario A; Larocca LM; Leone G
Haematologica; 1999 May; 84(5):419-24. PubMed ID: 10329920
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of biological variables in B-cell chronic lymphocytic leukemia. Can we improve upon clinical parameters?
Molica S
Haematologica; 1997; 82(6):705-9. PubMed ID: 9499672
[TBL] [Abstract][Full Text] [Related]
17. A scoring system based on the expression of six surface molecules allows the identification of three prognostic risk groups in B-cell chronic lymphocytic leukemia.
Zucchetto A; Bomben R; Dal Bo M; Sonego P; Nanni P; Rupolo M; Bulian P; Dal Maso L; Del Poeta G; Del Principe MI; Degan M; Gattei V
J Cell Physiol; 2006 May; 207(2):354-63. PubMed ID: 16331666
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation of murine B cell Fc gamma RII expression by CD4+ T helper subsets.
Snapper CM; Hooley JJ; Atasoy U; Finkelman FD; Paul WE
J Immunol; 1989 Oct; 143(7):2133-41. PubMed ID: 2528589
[TBL] [Abstract][Full Text] [Related]
19. CD38 expression in B-chronic lymphocytic leukemia: association with clinical presentation and outcome in 155 patients.
Domingo-Domènech E; Domingo-Clarós A; Gonzàlez-Barca E; Beneitez D; Alonso E; Romagosa V; De Sanjos S; Petit J; Grañena A; Fernández de Sevilla A
Haematologica; 2002 Oct; 87(10):1021-7. PubMed ID: 12368155
[TBL] [Abstract][Full Text] [Related]
20. Cellular expression and serum circulating levels of CD23 in B-cell chronic lymphocytic leukemia. Implications for prognosis.
Molica S; Levato D; Dell'Olio M; Matera R; Minervini M; Dattilo A; Carotenuto M; Musto P
Haematologica; 1996; 81(5):428-33. PubMed ID: 8952156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
